Published in Cancer Cell on May 18, 2010
Landscape of somatic retrotransposition in human cancers. Science (2012) 4.37
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell (2011) 3.58
Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev (2012) 3.44
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 2.38
Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain. Neuron (2011) 2.14
Manifestations and mechanisms of stem cell aging. J Cell Biol (2011) 1.93
Cancer stem cells in glioblastoma. Genes Dev (2015) 1.91
From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A (2013) 1.71
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J Pathol (2013) 1.71
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep (2013) 1.35
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. Cell Rep (2014) 1.34
Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk. Genes Cancer (2013) 1.28
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol (2011) 1.27
FoxM1 and Wnt/β-catenin signaling in glioma stem cells. Cancer Res (2012) 1.26
Transcriptome analysis of neural progenitor cells by a genetic dual reporter strategy. Stem Cells (2011) 1.21
Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal (2013) 1.10
Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci (2012) 1.10
Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol (2012) 1.09
Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis (2013) 1.08
Epigenetic regulation by chromatin activation mark H3K4me3 in primate progenitor cells within adult neurogenic niche. Sci Rep (2014) 1.07
Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. Cancer Res (2011) 1.04
Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal. J Cell Mol Med (2012) 1.00
β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells. Chemother Res Pract (2012) 0.99
Let-7 and miR-125 cooperate to prime progenitors for astrogliogenesis. EMBO J (2015) 0.95
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer (2011) 0.95
Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proc Natl Acad Sci U S A (2015) 0.93
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget (2015) 0.93
Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts. Genes Dev (2013) 0.91
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. Neuro Oncol (2012) 0.91
Comparative analysis of methods for identifying recurrent copy number alterations in cancer. PLoS One (2012) 0.88
Glioma Stem Cells: Signaling, Microenvironment, and Therapy. Stem Cells Int (2016) 0.88
Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme. Front Oncol (2013) 0.87
Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth. PLoS One (2012) 0.87
Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761®) after permanent ischemic stroke in mice. Mol Neurobiol (2013) 0.86
Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44. Exp Ther Med (2011) 0.86
CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression. Oncotarget (2014) 0.86
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway. Neuro Oncol (2013) 0.85
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis (2013) 0.85
WNT signaling in glioblastoma and therapeutic opportunities. Lab Invest (2015) 0.84
Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma. Cancer Res (2015) 0.84
Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. Mol Cell Biol (2013) 0.84
Integrative functional genomics identifies RINT1 as a novel GBM oncogene. Neuro Oncol (2012) 0.84
Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Res (2015) 0.82
Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema. Lung Cancer (2011) 0.82
Crosstalk of the Wnt/β-catenin pathway with other pathways in cancer cells. Genes Dis (2016) 0.81
Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells. Mol Cancer Ther (2013) 0.81
In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma. Oncotarget (2015) 0.80
Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord. Int J Clin Exp Pathol (2015) 0.80
A microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer. Oncol Lett (2011) 0.80
Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells. PLoS One (2013) 0.80
A new tumour suppressor enters the network of intestinal progenitor cell homeostasis. EMBO J (2012) 0.79
Identification of upstream regulators for prognostic expression signature genes in colorectal cancer. BMC Syst Biol (2013) 0.79
Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells. J Neuropathol Exp Neurol (2015) 0.78
A multipronged approach to the identification and study of an important oncogene in GBM. Cancer Cell (2010) 0.77
The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. Int J Clin Exp Pathol (2014) 0.77
Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt Pathway. Transl Stroke Res (2015) 0.77
Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion. Cell Cycle (2015) 0.77
Radioresistance of Brain Tumors. Cancers (Basel) (2016) 0.76
The crossroads between cancer stem cells and aging. BMC Cancer (2015) 0.76
Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells. J Mol Genet Med (2013) 0.75
ZEB1 regulates glioma stemness through LIF repression. Sci Rep (2017) 0.75
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy. Front Pharmacol (2016) 0.75
Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer. PLoS One (2016) 0.75
Ceramide is involved in alcohol-induced neural proliferation. Neural Regen Res (2013) 0.75
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway. Oncotarget (2017) 0.75
Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells. Oncotarget (2016) 0.75
Overcoming therapeutic resistance in glioblastoma: the way forward. J Clin Invest (2017) 0.75
Epigenetics in cancer stem cells. Mol Cancer (2017) 0.75
Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor. Curr Pharm Des (2015) 0.75
The Crossroads of Neural Stem Cell Development and Tumorigenesis. Opera Med Physiol (2016) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
Mammalian neural stem cells. Science (2000) 16.09
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature (2003) 11.23
Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science (2002) 7.92
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature (2001) 7.44
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell (2009) 6.77
Stem cell concepts renew cancer research. Blood (2008) 6.74
Tissue repair and stem cell renewal in carcinogenesis. Nature (2004) 6.28
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development (2004) 6.21
Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol (2001) 5.95
Brain tumour stem cells. Nat Rev Cancer (2006) 5.84
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
The development of neural stem cells. Nature (2001) 5.54
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Acute promyelocytic leukemia: from highly fatal to highly curable. Blood (2008) 5.35
PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron (2006) 5.34
Radial glia cells are candidate stem cells of ependymoma. Cancer Cell (2005) 5.21
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature (2008) 5.00
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell (2008) 4.71
Self-renewal and solid tumor stem cells. Oncogene (2004) 4.60
Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer (2007) 4.54
Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev (2008) 4.38
Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron (2000) 4.18
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell (2009) 3.89
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87
A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci (2001) 3.86
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev (2002) 3.80
Wnt signaling and stem cell control. Cell Res (2008) 3.53
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell (2004) 3.30
Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell (2007) 3.14
beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol (2003) 2.85
Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res (1998) 2.33
Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest (1992) 2.30
Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A (2008) 2.15
Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res (2005) 2.08
Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell (2009) 2.04
Neural stem cell isolation and characterization. Methods Enzymol (2006) 2.03
Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet (1997) 1.92
Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res (1988) 1.78
Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res (2007) 1.60
Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res (2001) 1.60
Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells (2007) 1.53
Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood (1979) 1.45
APC mutations in sporadic medulloblastomas. Am J Pathol (2000) 1.40
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood (2004) 1.26
Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem (1998) 1.25
The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev (2002) 1.22
Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol (2002) 1.14
AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene (2003) 1.13
The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res (2002) 1.08
Cancer stem cells in brain tumor biology. Cold Spring Harb Symp Quant Biol (2009) 1.02
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
International network of cancer genome projects. Nature (2010) 20.35
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
A landscape of driver mutations in melanoma. Cell (2012) 12.61
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell (2007) 12.33
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A (2004) 12.30
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A (2007) 11.85
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science (2007) 10.60
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer (2006) 10.05
Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell (2004) 9.41
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature (2006) 9.20
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell (2007) 8.94
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 8.37
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev (2003) 8.27
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell (2004) 8.16
Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 8.07
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet (2009) 7.81
Melanoma genome sequencing reveals frequent PREX2 mutations. Nature (2012) 7.77
The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell (2004) 7.77
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A (2008) 7.45
Pancreatic cancer biology and genetics. Nat Rev Cancer (2002) 7.36
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 6.89
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature (2005) 6.86
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell (2009) 6.55
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 6.53
High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A (2005) 6.52
Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2011) 6.36
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18
Pancreatic cancers require autophagy for tumor growth. Genes Dev (2011) 6.17
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature (2002) 6.10
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med (2005) 6.04
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90
How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol (2007) 5.80
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature (2007) 5.65
Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63
A genetic screen for candidate tumor suppressors identifies REST. Cell (2005) 5.61
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov (2011) 5.30
DNA breaks and chromosome pulverization from errors in mitosis. Nature (2012) 5.19
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell (2006) 5.01